META PHARMA
META PHARMA, also known as Meta Biopharma, is a leading player in the pharmaceutical industry, headquartered in China (CN). Founded in the early 2000s, the company has established a strong presence in major operational regions across Asia and beyond, focusing on innovative biopharmaceutical solutions. Specialising in the development and manufacturing of advanced therapeutics, META PHARMA is renowned for its unique approach to drug formulation and delivery systems. The company’s core products include biologics and biosimilars, which are designed to address unmet medical needs with enhanced efficacy and safety profiles. With a commitment to research and development, META PHARMA has achieved significant milestones, positioning itself as a trusted name in the market. Its dedication to quality and innovation has garnered recognition, making it a key contributor to the global healthcare landscape.
DitchCarbon Score
How does META PHARMA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
META PHARMA's score of 0 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
META PHARMA's reported carbon emissions
META PHARMA, headquartered in CN, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. However, the pharmaceutical industry is increasingly focusing on reducing carbon footprints and enhancing sustainability practices. As such, it is essential for companies like META PHARMA to establish clear climate commitments and measurable targets to align with global efforts in combating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
META PHARMA is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
